Cargando…

Fertility patients and their prescriptions: a two-year audit of patient-pharmacist interactions in a reproductive endocrinology practice

BACKGROUND: This study assessed pharmacy performance and satisfaction as reported by patients during ovulation induction therapy. MATERIALS AND METHODS: Patients (n = 1269) receiving gonadotropin prescriptions for intrauterine insemination or in vitro fertilisation-embryo transfer in 2007–2008 were...

Descripción completa

Detalles Bibliográficos
Autores principales: Sills, Eric Scott, Shurpyak, Serhiy A, Gorman, Deirdre J, Shkrobot, Lyuda V, Murray, Grainne U, O'Connor, Beppi MG, Rapple, Una E, Fogarty, Alicia O, Svarkova, Pavlina, Brickell, Kathy M, Walsh, David J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727501/
https://www.ncbi.nlm.nih.gov/pubmed/19650890
http://dx.doi.org/10.1186/1755-7682-2-24
_version_ 1782170679403085824
author Sills, Eric Scott
Shurpyak, Serhiy A
Gorman, Deirdre J
Shkrobot, Lyuda V
Murray, Grainne U
O'Connor, Beppi MG
Rapple, Una E
Fogarty, Alicia O
Svarkova, Pavlina
Brickell, Kathy M
Walsh, David J
author_facet Sills, Eric Scott
Shurpyak, Serhiy A
Gorman, Deirdre J
Shkrobot, Lyuda V
Murray, Grainne U
O'Connor, Beppi MG
Rapple, Una E
Fogarty, Alicia O
Svarkova, Pavlina
Brickell, Kathy M
Walsh, David J
author_sort Sills, Eric Scott
collection PubMed
description BACKGROUND: This study assessed pharmacy performance and satisfaction as reported by patients during ovulation induction therapy. MATERIALS AND METHODS: Patients (n = 1269) receiving gonadotropin prescriptions for intrauterine insemination or in vitro fertilisation-embryo transfer in 2007–2008 were prospectively interviewed by nurses and/or completed a structured questionnaire to evaluate pharmacy performance. "Community" (n = 12) and "specialty" (n = 2) pharmacy status (C vs. S) was defined by each pharmacy, and all pharmacies were selected by patients before cycle start. Patient comments about their pharmacy were classified into five types: i) Dispensing error-gonadotropin, ii) Dispensing error-non gonadotropin, iii) Mistake in prescribed medical equipment/supplies, iv) Counselling/communication inaccuracy, and v) Inventory problem or other. RESULTS: 391 pharmacy concerns were reported from 150 fertility patients during the study period. The majority (75.9%) of patients selected a S pharmacy to fill their prescriptions, and this pharmacy type was identified in 2.8% of adverse pharmacy encounters (p < 0.0001). Non-gonadotropin prescriptions filled at C pharmacies accounted for 40.2% of all complaints, followed by problems with prescriptions for supplies (20.2%) and gonadotropins (18.7%) at C pharmacies. Patient conflict involving S pharmacies was limited (n = 11), and related to operating hours and medication delivery logistics. CONCLUSION: Fertility patients reported a disproportionate and significantly higher number of adverse pharmacy encounters from C pharmacies compared to S pharmacies. Although no licensing mechanism in Ireland currently recognises special training or certification in any area of pharmacy practice, informal self-designations by pharmacies remain a useful discriminator. Level of familiarity with fertility medicines and availability of inventory are important characteristics to be considered when counselling fertility patients about pharmacy choice. Those who select a C pharmacy should be advised to allow extra time for inventory verification, order confirmation, and additional counselling. Additional study is needed to determine if a minimum volume of fertility-related prescriptions is necessary to assure competence in this particular field of pharmacy practice.
format Text
id pubmed-2727501
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27275012009-08-15 Fertility patients and their prescriptions: a two-year audit of patient-pharmacist interactions in a reproductive endocrinology practice Sills, Eric Scott Shurpyak, Serhiy A Gorman, Deirdre J Shkrobot, Lyuda V Murray, Grainne U O'Connor, Beppi MG Rapple, Una E Fogarty, Alicia O Svarkova, Pavlina Brickell, Kathy M Walsh, David J Int Arch Med Original Research BACKGROUND: This study assessed pharmacy performance and satisfaction as reported by patients during ovulation induction therapy. MATERIALS AND METHODS: Patients (n = 1269) receiving gonadotropin prescriptions for intrauterine insemination or in vitro fertilisation-embryo transfer in 2007–2008 were prospectively interviewed by nurses and/or completed a structured questionnaire to evaluate pharmacy performance. "Community" (n = 12) and "specialty" (n = 2) pharmacy status (C vs. S) was defined by each pharmacy, and all pharmacies were selected by patients before cycle start. Patient comments about their pharmacy were classified into five types: i) Dispensing error-gonadotropin, ii) Dispensing error-non gonadotropin, iii) Mistake in prescribed medical equipment/supplies, iv) Counselling/communication inaccuracy, and v) Inventory problem or other. RESULTS: 391 pharmacy concerns were reported from 150 fertility patients during the study period. The majority (75.9%) of patients selected a S pharmacy to fill their prescriptions, and this pharmacy type was identified in 2.8% of adverse pharmacy encounters (p < 0.0001). Non-gonadotropin prescriptions filled at C pharmacies accounted for 40.2% of all complaints, followed by problems with prescriptions for supplies (20.2%) and gonadotropins (18.7%) at C pharmacies. Patient conflict involving S pharmacies was limited (n = 11), and related to operating hours and medication delivery logistics. CONCLUSION: Fertility patients reported a disproportionate and significantly higher number of adverse pharmacy encounters from C pharmacies compared to S pharmacies. Although no licensing mechanism in Ireland currently recognises special training or certification in any area of pharmacy practice, informal self-designations by pharmacies remain a useful discriminator. Level of familiarity with fertility medicines and availability of inventory are important characteristics to be considered when counselling fertility patients about pharmacy choice. Those who select a C pharmacy should be advised to allow extra time for inventory verification, order confirmation, and additional counselling. Additional study is needed to determine if a minimum volume of fertility-related prescriptions is necessary to assure competence in this particular field of pharmacy practice. BioMed Central 2009-08-03 /pmc/articles/PMC2727501/ /pubmed/19650890 http://dx.doi.org/10.1186/1755-7682-2-24 Text en Copyright © 2009 Sills et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Sills, Eric Scott
Shurpyak, Serhiy A
Gorman, Deirdre J
Shkrobot, Lyuda V
Murray, Grainne U
O'Connor, Beppi MG
Rapple, Una E
Fogarty, Alicia O
Svarkova, Pavlina
Brickell, Kathy M
Walsh, David J
Fertility patients and their prescriptions: a two-year audit of patient-pharmacist interactions in a reproductive endocrinology practice
title Fertility patients and their prescriptions: a two-year audit of patient-pharmacist interactions in a reproductive endocrinology practice
title_full Fertility patients and their prescriptions: a two-year audit of patient-pharmacist interactions in a reproductive endocrinology practice
title_fullStr Fertility patients and their prescriptions: a two-year audit of patient-pharmacist interactions in a reproductive endocrinology practice
title_full_unstemmed Fertility patients and their prescriptions: a two-year audit of patient-pharmacist interactions in a reproductive endocrinology practice
title_short Fertility patients and their prescriptions: a two-year audit of patient-pharmacist interactions in a reproductive endocrinology practice
title_sort fertility patients and their prescriptions: a two-year audit of patient-pharmacist interactions in a reproductive endocrinology practice
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727501/
https://www.ncbi.nlm.nih.gov/pubmed/19650890
http://dx.doi.org/10.1186/1755-7682-2-24
work_keys_str_mv AT sillsericscott fertilitypatientsandtheirprescriptionsatwoyearauditofpatientpharmacistinteractionsinareproductiveendocrinologypractice
AT shurpyakserhiya fertilitypatientsandtheirprescriptionsatwoyearauditofpatientpharmacistinteractionsinareproductiveendocrinologypractice
AT gormandeirdrej fertilitypatientsandtheirprescriptionsatwoyearauditofpatientpharmacistinteractionsinareproductiveendocrinologypractice
AT shkrobotlyudav fertilitypatientsandtheirprescriptionsatwoyearauditofpatientpharmacistinteractionsinareproductiveendocrinologypractice
AT murraygrainneu fertilitypatientsandtheirprescriptionsatwoyearauditofpatientpharmacistinteractionsinareproductiveendocrinologypractice
AT oconnorbeppimg fertilitypatientsandtheirprescriptionsatwoyearauditofpatientpharmacistinteractionsinareproductiveendocrinologypractice
AT rappleunae fertilitypatientsandtheirprescriptionsatwoyearauditofpatientpharmacistinteractionsinareproductiveendocrinologypractice
AT fogartyaliciao fertilitypatientsandtheirprescriptionsatwoyearauditofpatientpharmacistinteractionsinareproductiveendocrinologypractice
AT svarkovapavlina fertilitypatientsandtheirprescriptionsatwoyearauditofpatientpharmacistinteractionsinareproductiveendocrinologypractice
AT brickellkathym fertilitypatientsandtheirprescriptionsatwoyearauditofpatientpharmacistinteractionsinareproductiveendocrinologypractice
AT walshdavidj fertilitypatientsandtheirprescriptionsatwoyearauditofpatientpharmacistinteractionsinareproductiveendocrinologypractice